Strong Interactive Momentum and Strategic Evolution Position Inspired for Growth and Margin Expansion Revenue of $86.2 million, up 12% over prior year, driven primarily by record Interactive revenue, up 48% year-over-yearNet Operating Income of $9.7 million, Net Loss of $1.9 million and Adjusted Net Income of $8.3 millionAdjusted EBITDA of $32.3 million, up 11% from prior year, driven by all-time-high Interactive Adjusted EBITDA, up 55% year-over-yearSale of UK holiday parks business and certain associated ...

Company’s strategic focus and highest priority is now the advancement of the 4WARD Phase 3 chronic neutropenia trialPreviously announced workforce reductions resulted in $13M annualized cost savingsSuccessful completion of two financial transactions totaling $240.3M; cash runway now extends to the end of 2028 BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today reported financial results for the thir ...

Total revenue growth of 6% with 19% AMS/DRS organic growth AMS/DRS increased to 27% of trailing-twelve-month revenue Record third-quarter operating profit margin and EBITDA margin RICHMOND, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions (DRS), and ATM managed services (AMS), today announced third-quarter results. Mark Eubanks, president and CEO, said: “We delivered a strong third quarter, above the m ...

– Phase 3 LUGANO and LUCIA clinical trials for DURAVYU™ in wet AMD fully enrolled and on track for data readout beginning in mid-2026 – – Announced initiation of pivotal Phase 3 DME program consisting of two identical non-inferiority trials, COMO and CAPRI; first patient dosing anticipated in Q1 2026 – – Announced preclinical data demonstrating DURAVYU’s potential as a multi-target treatment inhibiting both VEGF-mediated vascular permeability and IL-6 mediated inflammation, key contributors to wet AMD and D ...

PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that Will Chou, M.D., president and chief executive officer, will participate in a fireside chat during the Guggenheim Securities 2nd Annual Healthcare Innovation Conference on Wednesday, November 12, 2025 at 9:30 a.m. ET in Boston, MA. A live webcast of the event will be available on the Inves ...

亚利桑那州项目进展 - 公司已将近期钻探样本及部分先前岩心样本运送至多家经认证的独立实验室进行多种化验分析 [1] - 皮纳尔县项目区的土地管理局矿权地存在历史化验结果 显示砂矿通道中存在金及其他贵金属沉积迹象 据未经公司核实的的历史报告 金以微观形态存在 [2] - 基于历史化验结果和金的性质 公司正进行大量分析程序 包括破坏性和非破坏性技术 以确认先前报告的贵金属存在情况及估算浓度 并寻求确定品位及潜在回收工艺的最有效方法 [2] 科罗拉多州合作与实地考察 - 公司与Venture Gold Corp签署的意向书持续取得进展 管理层及顾问地质学家近期完成了对爱达荷斯普林斯矿区的为期五天的实地考察 [3] - 考察内容包括查看选矿厂址、遍布矿区的多个矿堆以及附近几个远景地段 [3] 代币化平台与合资企业 - 合作伙伴Arizore Ltd已签署合同 正在开发行业领先的贵金属代币化平台 [4] - 公司与Arizore Ltd计划制定一项总括性合资协议 旨在将多个项目纳入统一管理文件 以明确双方关系范围、当前及未来活动的条款与职责 [5] - 该总括协议有望加速未来收购的谈判进程 并促进项目融资和管理流程 使未来项目运作更高效和 streamlined [5] 公司管理层评论 - 公司首席执行官对科罗拉多州的实地考察及与Venture Gold管理层的多次会议表示满意 认为对方对爱达荷斯普林斯/中央城矿区的修复和再开发愿景明确 [6] - 首席执行官同时对与Arizore Ltd在代币化方面的持续发展及不断深化的合作关系表示满意 [6] 公司背景信息 - Bocana Resources Corp是一家矿产勘探公司 专注于北美和南美矿产资产的收购、勘探与开发 [8] - 公司通过全资子公司Huiracocha International Service SRL持有玻利维亚波托西省Sud Lipez省Escala区域矿权地的100%工作权益 该权益由Comibol授予 [8]

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ: PLBY) (the “Company” or “Playboy”) unveils its Winter 2025-26 issue, featuring the re-release of rarely seen, semi-nude images of Jane Birkin — the global icon and namesake of the world’s most famous handbag — originally published by the magazine in 1970. The pictorial is revisited through the lens of journalist Marisa Meltzer, whose new book It Girl explores Birkin’s enduring influence on women today. The issue officially hits newsstands ...

Flagship system marks Plug’s first commercial electrolyzer deployment in the Netherlands and serves as a path for future Dutch hydrogen hub developmentsSLINGERLANDS, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced it has started installation of its 5 MW electrolyzer for the H2 Hollandia project, the first decentralized green hydrogen hub initiative currently under construction in the Netherl ...

Total committed capital of US $140m for restart of Bogoso and Prestea mine secured from two separate institutional backers (US $75m Equity Line of Credit, still undrawn, and new US $65m1 secured loan) Blue Gold ready to drop litigation with the Government of Ghana if the lease dispute is resolved instantly Restart of Bogoso and Prestea mine ties in with Blue Gold’s strategy to tokenise gold to launch world’s first global gold-backed currency NEW YORK, NY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limit ...

– Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically significant and clinically meaningful effects on primary and key secondary endpoints when administered once every 12 weeks – – On-track to report top-line results from VALIANT Phase 2 trial in severe asthma in the first quarter of 2026 – – Enrollment ongoing in VENTURE Phase 2 trial in COPD; first patient dosed in July – WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. ...